Lixte Biotechnology (LIXT) Short Interest Ratio & Short Volume $1.52 +0.03 (+2.01%) (As of 11/21/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Lixte Biotechnology Short Interest DataLixte Biotechnology (LIXT) has a short interest of 448,000 shares, representing 24.89% of the float (the number of shares available for trading by the public). This marks a 2,348.09% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 342,008 shares to cover all short positions.Current Short Interest448,000 sharesPrevious Short Interest18,300 sharesChange Vs. Previous Month+2,348.09%Dollar Volume Sold Short$945,280.00Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares2,250,000 sharesFloat Size1,800,000 sharesShort Percent of Float24.89%Today's Trading Volume27,791 sharesAverage Trading Volume342,008 sharesToday's Volume Vs. Average8% Short Selling Lixte Biotechnology? Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLIXT Short Interest Over TimeLIXT Days to Cover Over TimeLIXT Percentage of Float Shorted Over Time Ad Behind the MarketsDemocrats Sold Out the American Dream - Are you ready?There's a massive housing crisis looming, and nobody on Main Street knows it yet... The Democrats sold out the American Dream - and now, millions of Americans are locked out of the housing market, forced to become "permanent renters."Click here to see exactly what you need to do >>> Lixte Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024448,000 shares $945,280.00 +2,348.1%24.9%0.7 $2.11 10/15/202418,300 shares $32,940.00 -26.5%1.0%0.4 $1.80 9/30/202424,900 shares $46,563.00 -28.0%1.4%0.5 $1.87 9/15/202434,600 shares $68,854.00 +10.9%1.9%0.7 $1.99 8/31/202431,200 shares $55,536.00 +225.0%1.7%0.4 $1.78 8/15/20249,600 shares $19,488.00 +20.0%0.5%0.2 $2.03 Get the Latest News and Ratings for LIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 7/31/20248,000 shares $17,280.00 -33.3%0.4%0.2 $2.16 7/15/202412,000 shares $28,920.00 -25.9%0.7%0.3 $2.41 6/30/202416,200 shares $38,394.00 -12.9%0.9%0.4 $2.37 6/15/202418,600 shares $45,570.00 +53.7%1.0%0 $2.45 5/31/202412,100 shares $28,291.01 -24.8%0.7%0 $2.34 5/15/202416,100 shares $36,869.00 -31.8%0.9%0 $2.29 4/30/202423,600 shares $68,204.00 -71.5%1.3%0 $2.89 4/15/202482,700 shares $272,910.00 +395.2%4.6%0.2 $3.30 3/31/202416,700 shares $56,446.00 -14.8%1.0%0 $3.38 3/15/202419,600 shares $45,276.00 -62.3%1.1%0.5 $2.31 2/29/202452,000 shares $135,200.00 +258.6%3.0%1.4 $2.60 2/15/202414,500 shares $39,440.00 +42.2%0.8%0.3 $2.72 1/31/202410,200 shares $21,063.00 +117.0%0.6%0.4 $2.07 1/15/20244,700 shares $9,118.00 -63.0%0.3%0.1 $1.94 12/31/202312,700 shares $29,845.00 -32.5%0.7%0.3 $2.35 12/15/202318,800 shares $39,668.00 -26.0%1.1%0.4 $2.11 11/30/202325,400 shares $59,182.00 -60.1%1.5%0.5 $2.33 11/15/202363,700 shares $184,730.00 +295.7%3.7%1.2 $2.90 10/31/202316,100 shares $38,720.50 -1.8%0.9%0.4 $2.41 10/15/202316,400 shares $39,360.00 -44.6%1.0%0.3 $2.40 9/30/202329,600 shares $72,520.00 +261.0%2.1%0.2 $2.45 9/15/20238,200 shares $17,384.00 +13.9%0.6%0.1 $2.12 8/31/20237,200 shares $18,036.00 -44.2%0.3%0.1 $2.51 8/15/202312,900 shares $32,250.00 -84.3%0.6%0.1 $2.50 7/31/202382,200 shares $289,344.00 +774.5%4.7%0.6 $3.52 7/15/20239,400 shares $51,042.00 +8.1%1.0%0.1 $5.43 6/30/20238,700 shares $50,721.00 -28.7%0.5%0.4 $5.83 6/15/202312,200 shares $57,950.00 +306.7%1.5%0.7 $4.75 5/31/20233,000 shares $20,784.00 -86.2%0.4%0.3 $6.93 5/15/202321,800 shares $14,483.92 +162.7%0.3%0.2 $0.66 4/30/20238,300 shares $4,656.30 -80.0%0.1%0 $0.56 4/15/202341,500 shares $26,153.30 -45.8%0.5%0 $0.63 3/31/202376,500 shares $63,288.45 -39.1%1.0%0.1 $0.83 3/15/2023125,700 shares $85,853.10 +31.5%1.7%0.1 $0.68What Comes Next Could Be a Once-in-a-Lifetime Opportunity (Ad)A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today. 2/28/202395,600 shares $86,757.00 -38.7%1.3%0.1 $0.91 2/15/2023156,000 shares $180,960.00 +459.1%2.1%0.1 $1.16 1/31/202327,900 shares $22,041.00 -62.6%0.4%0 $0.79 1/15/202374,500 shares $42,465.00 +89.1%1.0%2 $0.57 12/30/202239,400 shares $20,054.60 -7.9%0.5%1.2 $0.51 12/15/202242,800 shares $23,171.92 -15.9%0.6%1.7 $0.54 11/30/202250,900 shares $38,938.50 +53.3%0.7%1.8 $0.77 11/15/202233,200 shares $18,283.24 +26.7%0.5%1.1 $0.55 10/31/202226,200 shares $13,105.24 +5.2%0.4%0.5 $0.50 10/15/202224,900 shares $12,980.37 -58.5%0.4%0.2 $0.52 9/30/202260,000 shares $33,612.00 +64.4%0.9%0.5 $0.56 9/15/202236,500 shares $25,761.70 -43.4%0.5%0.3 $0.71 8/31/202264,500 shares $50,310.00 -30.0%0.9%0.5 $0.78 8/15/202292,100 shares $74,582.58 +435.5%1.3%0.6 $0.81 7/31/202217,200 shares $12,934.40 -27.4%0.2%0.1 $0.75 7/15/202223,700 shares $19,434.00 +0.9%0.3%0 $0.82 6/30/202223,500 shares $17,496.93 -20.3%0.3%0 $0.74 6/15/202229,500 shares $21,537.95 -38.3%0.4%0 $0.73 5/31/202247,800 shares $35,873.90 -12.3%0.7%0 $0.75 5/15/202254,500 shares $51,824.05 -59.9%0.8%0 $0.95 4/30/2022136,000 shares $160,480.00 -92.4%2.7%0 $1.18 4/15/20221,800,000 shares $2.83 million +10,614.3%35.2%0.6 $1.57 3/31/202216,800 shares $20,664.00 +8.4%0.4%0.1 $1.23 3/15/202215,500 shares $17,050.00 -59.2%0.3%0 $1.10 2/28/202238,000 shares $53,960.00 -9.5%0.7%0 $1.42 2/15/202242,000 shares $68,460.00 -66.0%0.7%0 $1.63 1/31/2022123,600 shares $239,784.00 -62.3%2.2%0.1 $1.94 1/15/2022328,200 shares $643,272.00 +589.5%5.8%0.2 $1.96 12/31/202147,600 shares $56,644.00 +14.2%0.8%0 $1.19 12/15/202141,700 shares $57,963.00 +110.6%0.7%0.8 $1.39 11/30/202119,800 shares $32,274.00 -54.2%0.4%0.4 $1.63 11/15/202143,200 shares $78,192.00 -20.2%0.8%0.9 $1.81 10/29/202154,100 shares $101,708.00 +0.4%1.0%0.7 $1.88 10/15/202153,900 shares $100,793.00 +11.4%1.0%0.1 $1.87 9/30/202148,400 shares $100,672.00 +25.4%0.9%0.1 $2.08 9/15/202138,600 shares $84,148.00 +196.9%0.7%0.1 $2.18 8/31/202113,000 shares $31,980.00 -80.7%0.2%0 $2.46 8/13/202167,400 shares $150,976.00 +2,006.3%1.2%0.2 $2.24 7/30/20213,200 shares $8,800.00 -82.4%0.1%0 $2.75 7/15/202118,200 shares $54,418.00 -37.5%0.3%0.1 $2.99 6/30/202129,100 shares $88,173.00 +193.9%0.5%0.1 $3.03 6/15/20219,900 shares $29,304.00 -66.9%0.2%0 $2.96 5/28/202129,900 shares $81,926.00 +81.2%0.5%0.1 $2.74 5/14/202116,500 shares $42,817.50 -45.7%0.3%0 $2.60 4/30/202130,400 shares $87,856.00 +98.7%0.5%0 $2.89 4/15/202115,300 shares $45,441.00 -62.7%0.3%0 $2.97 3/31/202141,000 shares $132,020.00 +151.5%1.0%0 $3.22 3/15/202116,300 shares $71,231.00 -13.8%0.4%0 $4.37 2/26/202118,900 shares $71,253.00 +575.0%0.5%0 $3.77 2/12/20212,800 shares $10,220.00 +64.7%0.1%0 $3.65What Comes Next Could Be a Once-in-a-Lifetime Opportunity (Ad)A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today. 1/29/20211,700 shares $5,346.50 -15.0%0.1%0 $3.15 1/15/20212,000 shares $6,520.00 No Change0.1%0 $3.26 11/15/20208,400 shares $9,492.00 +140.0%N/A2.8 $1.13 10/30/20203,500 shares $3,920.00 +2.9%N/A3.9 $1.12 10/15/20203,400 shares $3,910.00 +17.2%N/A2.1 $1.15 9/30/20202,900 shares $3,393.00 +107.1%N/A1.4 $1.17 9/15/20201,400 shares $1,400.00 +40.0%N/A0.1 $1.00 8/31/20201,000 shares $1,180.00 -9.1%N/A0.3 $1.18 8/14/20201,100 shares $1,298.00 +37.5%N/A0.7 $1.18 7/31/2020800 shares $952.00 -84.0%N/A0.1 $1.19 7/15/20205,000 shares $4,400.00 -2.0%N/A1.4 $0.88 6/30/20205,100 shares $4,590.00 +13.3%N/A3 $0.90 6/15/20204,500 shares $4,050.00 +12.5%N/A3.2 $0.90 5/29/20204,000 shares $3,520.00 No ChangeN/A1 $0.88 5/15/20204,000 shares $3,600.00 -36.5%N/A1.1 $0.90 4/30/20206,300 shares $5,607.00 +26.0%N/A2.4 $0.89 4/15/20205,000 shares $5,000.00 +284.6%N/A0.9 $1.00 3/31/20201,300 shares $1,274.00 +225.0%N/A0.3 $0.98 3/13/2020400 shares $355.60 No ChangeN/A0.2 $0.89 2/28/2020400 shares $368.00 -66.7%N/A0 $0.92 2/14/20201,200 shares $1,068.00 +50.0%N/A0.1 $0.89 1/31/2020800 shares $599.92 No ChangeN/A0.2 $0.75 1/15/2020800 shares $551.20 +100.0%N/A0.3 $0.69 12/31/2019400 shares $280.00 -86.7%N/A0 $0.70 LIXT Short Interest - Frequently Asked Questions What is Lixte Biotechnology's current short interest? Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 448,000 shares of LIXT short. 24.89% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest. What is a good short interest ratio for Lixte Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LIXT shares currently have a short interest ratio of 1.0. Learn More on Lixte Biotechnology's short interest ratio. What is a good short interest percentage for Lixte Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 24.89% of Lixte Biotechnology's floating shares are currently sold short. Is Lixte Biotechnology's short interest increasing or decreasing? Lixte Biotechnology saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 448,000 shares, an increase of 2,348.1% from the previous total of 18,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lixte Biotechnology's float size? Lixte Biotechnology currently has issued a total of 2,250,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 1,800,000 shares. How does Lixte Biotechnology's short interest compare to its competitors? 24.89% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lixte Biotechnology: PharmaCyte Biotech, Inc. (0.87%), Sol-Gel Technologies Ltd. (0.39%), NLS Pharmaceutics Ltd. (1.27%), ANEW Medical, Inc. (1.67%), Sensei Biotherapeutics, Inc. (1.18%), Aspira Women's Health Inc. (4.86%), Talphera, Inc. (0.60%), Eagle Pharmaceuticals, Inc. (2.90%), Turnstone Biologics Corp. (2.69%), ImmunoPrecise Antibodies Ltd. (3.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Lixte Biotechnology stock? Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. LIXT shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lixte Biotechnology? A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further. How often is Lixte Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies PMCB Short Interest Data SLGL Short Interest Data NLSP Short Interest Data WENA Short Interest Data SNSE Short Interest Data AWH Short Interest Data TLPH Short Interest Data EGRX Short Interest Data TSBX Short Interest Data IPA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LIXT) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
